Introduction
The proportion of patients with end-stage renal disease (ESRD) caused by diabetes has progressively increased during the last few decades and diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD) in the world. Diabetic nephropathy is defined by persistent albuminuria, declining glomerular filtration rate (GFR) and progressive rise in blood pressure. Approximately 40-50% of patients with type 1 diabetes and 20-30% of patients with type 2 diabetes develop diabetic nephropathy 1 . Based on studies in type 1 diabetes, it had been generally considered that once overt diabetic nephropathy, manifesting as persistent proteinuria, is present, it was only possible to slow, but not halt, the progression toward ESRD [2] [3] [4] . This led investigators during the early 1980s to search for early predictors of diabetic nephropathy. Most investigators now agree that diabetic nephropathy result from the interaction of multiple metabolic, genetic and other factors of which chronic hyperglycemia is one of the most significant factor in both the initiation and progression of the disease 5 . Different randomized controlled trials and observational studies have strongly suggest that hyperglycaemia or closely associated factors of poor glycaemic control, like HbA1c is a good predictor of diabetic nephropathy [5] [6] [7] [8] [9] , and is highly correlated with fasting blood glucose (FBG) and does not require measurement in the fasting state 10 . One study showed that increasing HbA1c categories had a higher prevalence of chronic kidney disease (CKD) and micro or macro-albuminuria. In the multivariable models, HbA1c categories above 7.0% were significantly associated with increased prevalence of diabetic nephropathy compared with the lowest category 11 .
Another study demonstrated that HbA1c >6.5% predicts a future risk of kidney disease. Above the threshold point with the increasing of HbA1c levels the risk of kidney diseases also increases sequentially 12 . It indicates that HbA1c may be used as a useful marker for nephropathy along with other risk factors. The ADVANCE trial documented that (in subjects with type 2 diabetes mellitus) strict glycaemic control (mean HbA1c: 6.5%) in comparison with standard control (mean HbA1c: 7.3%) is associated with a significant reduction in renal events, including onset of or worsening of nephropathy [hazard ratio (HR) 0.79; P = 0.006], new-onset microalbuminuria (HR 0.91; P = 0.02), and, in particular, development of macroalbuminuria (HR 0.70; P <0.001) 13 .
There are several other predictors [14] [15] [16] [17] [18] 
Materials and Methods
This is a cross-sectional study in type 2 diabetic patients under follow-up in the outpatient department (OPD) of BIRDEM hospital from January 2014 to December 2014. The study enrolled 400 type 2 diabetic patients of both gender and age group 30-60 years as study participants. The average duration of type 2 diabetes for the population was approximately 6.41 years ranging from 2 to 10 years. Patients with other chronic illnesses like chronic hepatic diseases, chronic arthritis etc. those may interfere with the blood glucose levels, pregnant diabetic cases or gestational diabetes, type 1 diabetics and patients of hemoglobinopathies were excluded from the study. We availed the information of the patients from their 'diabetic guide book'. This registered medical record book contained all records of baseline information and recorded necessary advice to diabetes management for subsequent follow-up visit.
In this study we collected data about sociodemographic information (age, sex, family history of diabetes, geographical location, socioeconomic factor, educational history, occupational history), lifestyle characteristics (physical activity, smoking history etc.), blood pressure and anthropometry (height, weight, calculated body mass index) of the participants. The duration of diabetes were also recorded. The selected patients were evaluated for the presence of nephropathy through the review of physicians' notes in the patients' medical report which were recorded in their diabetic guide book. The glycaemic status of the participants were assessed by HbA1c, FBG and 2 hours ABF. In this study we categorized the study participants into 3 groups by 3 HbA1c categories. These were good control group (HbA1c <7.0%), average control group (HbA1c 7-7.9%) and poor control group (HbA1c 8.0%). We compared the participants in these 3 HbA1c categories. HbA1c was measured by BIO-RAD variant which was modified HPLC method. Serum creatinine levels and fasting lipid profile were also measured. (Table IV) . were significantly associated with nephropathy (Table  II) . (Table IV) . 
Discussion
In our study the prevalence of nephropathy was 24.0% with male 27.1% and female 21.8%. In a study conducted in India showed the prevalence of nephropathy was 20% 14 . Another study revealed that prevalence of nephropathy was 32.5% in India 15 . A lower prevalence of proteinuria (19.7%) was found in another study 20 . WHO multicentric study of vascular disease in diabetes, observed a wide geographic variation in prevalence of nephropathy i.e. 2.4% from Hong Kong, 23% from Delhi to 37% from Oklahoma, USA 21 . These geographical and population variation in prevalence of diabetic nephropathy could be due to real ethnic variation in the susceptibility to diabetic nephropathy i.e. genetics, poor glycaemic control, hypertension or other socioeconomic, cultural and environmental factors. Several studies indicated that HbA1c may show a glycaemic threshold with microand macro-vascular complications of diabetes, suggesting it may additionally be useful biomarker to identify individuals at risk for different vascular complications 11, 12, 22 . In this study we observed that increasing HbA1c categories above 7.0% were significantly associated with increased prevalence of nephropathy. Logistic regression models of univariate analysis showed that the risk of nephropathy strongly increased at the HbA1c categories 8%. Our results were consistent with Sabanayagam et. al. 11 who reported that increasing HbA1c categories had a higher prevalence of any retinopathy, mild retinopathy, moderate retinopathy, CKD, micro or macroalbuminuria and peripheral neuropathy. Another study 15 also found the similar association of HbA1c with retinopathy, nephropathy and neuropathy. Zoungas, et. al. 22 observed that for macrovascular events and death the apparent threshold of HbA1c level was 7.0%, and for microvascular events the level was 6.5%. They also revealed that above thresholds, a higher level of HbA1c was significantly associated with higher risks of macrovascular, microvascular events and death in a loglinear manner. Below these thresholds, there was no significant relationship between mean HbA1c level and risks. In our study there were relatively few diabetic nephropathy events observed at HbA1c levels less than 7.0% so we could not properly evaluate the HbA1c levels below 7.0% in diabetic nephropathy.
Many previous studies 14, 23, 24 found that age was the single most important time related variable for renal impairment. Significant association of duration of diabetes and nephropathy was observed by Varghese, et. al. 24 . Like them we also found that advanced age and duration of diabetes were important risk factors for nephropathy. This study also revealed that lack of physical exercise was independent risk factors for nephropathy. It may be postulated that changed life style, food habit, less physical activity and stress may interfere with the metabolic process for glycaemic control and subsequent vascular complications [16] [17] [18] . In our study we found nephropathy significantly associated with not urban participants. We found a strong association of hypertension with nephropathy. Both systolic and diastolic blood pressures were significantly associated with diabetic nephropathy. Earlier, some studies 15,20 also observed the positive association of hypertension with nephropathy. Poor glycaemic control indicated by raised mean HbA1c, blood glucose levels in fasting and 2 hours after breakfast were significantly associated with increased prevalence of nephropathy in this study. These findings were consistent with other studies 15, 25 . Viswanathan et. al. 25 found that the initial HbA1c along with initial systolic blood pressure was an important contributory factor for proteinuria. The strong relation of poor glycaemic control and nephropathy was also observed by Agrawal et. al. 15 . In this study we could not assess the urinary protein level of the participants because of our limitation. Proteinuria is an important contributing factor of nephropathy [14] [15] [16] [17] [18] .
Conclusions
Our data from hospital based type 2 diabetic patients suggest that higher HbA1c levels >7% are significant risk factor of nephropathy and the risk increases markedly at HbA1c levels 8%. The prevalence and risk of diabetic nephropathy increased with advanced age, longer duration of diabetes, hypertension, poor glycaemic control, lacking of physical exercise etc. We should tightly control HbA1c and all other risk factors by appropriate preventive measures, so that the occurrence and worsening of diabetic nephropathy among type 2 diabetic patients could be prevented or atleast delayed.
